Search results
Jump to navigation
Jump to search
- For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider:4 KB (597 words) - 08:16, 6 September 2013
- * {{search link|inspite||ns0|ns14|ns100}} (in spite, inspire)16 KB (2,039 words) - 09:16, 2 March 2024